Comparison 6. Topical NSAID versus active comparator.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinical success ‐ topical piroxicam vs topical indomethacin	3	641	Risk Ratio (M‐H, Fixed, 95% CI)	1.24 [1.07, 1.44]
2 Local adverse events ‐ topical piroxicam vs topical indomethacin	3	671	Risk Ratio (M‐H, Fixed, 95% CI)	0.21 [0.09, 0.47]